首页> 美国卫生研究院文献>The Malaysian Journal of Medical Sciences : MJMS >Clinical Determinants of Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Differentiated Thyroid Cancer Patients with Elevated Thyroglobulin and Negative 131Iodine Whole Body Scans after 131Iodine Therapy
【2h】

Clinical Determinants of Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Differentiated Thyroid Cancer Patients with Elevated Thyroglobulin and Negative 131Iodine Whole Body Scans after 131Iodine Therapy

机译:甲状腺碘球蛋白升高和131碘治疗后131碘全身扫描阴性的分化型甲状腺癌患者的氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描的临床决定因素

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Background:A cross-sectional prospective study has been conducted on differentiated thyroid cancer (DTC) patients using negative 131Iodine (131I) whole body scans and elevated thyroglobulin (Tg) levels. The main objective of this research was to determine the prevalence of the conversion of differentiated to dedifferentiated thyroid cancer patients during follow up at the Hospital Kuala Lumpur. It has been demonstrated that fluorodeoxyglucose (FDG) uptake is inversely proportional to the iodine concentration and to differentiation of the cells.
机译:背景:一项针对前瞻性研究的分化型甲状腺癌(DTC)患者使用阴性 131 碘( 131 I)全身扫描和甲状腺球蛋白(Tg)升高水平。这项研究的主要目的是确定在吉隆坡医院随访期间分化为未分化甲状腺癌患者的转化率。已经证明氟代脱氧葡萄糖(FDG)的摄取与碘浓度和细胞分化成反比。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号